Cerner Co. (NASDAQ:CERN) COO Michael Nill Sells 13,124 Shares
Cerner Co. (NASDAQ:CERN) COO Michael Nill sold 13,124 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $68.07, for a total value of $893,350.68. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Shares of NASDAQ:CERN traded down $0.09 during trading on Monday, reaching $67.76. The company had a trading volume of 1,003,627 shares, compared to its average volume of 2,390,813. The firm has a market capitalization of $21.65 billion, a price-to-earnings ratio of 30.66, a price-to-earnings-growth ratio of 1.92 and a beta of 0.92. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.52 and a quick ratio of 2.50. The stock’s fifty day moving average price is $70.02 and its 200 day moving average price is $67.07. Cerner Co. has a fifty-two week low of $48.78 and a fifty-two week high of $76.47.
Cerner (NASDAQ:CERN) last released its earnings results on Wednesday, July 24th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.58 by $0.02. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.44 billion. Cerner had a return on equity of 15.14% and a net margin of 10.75%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 earnings per share. On average, equities analysts anticipate that Cerner Co. will post 2.43 EPS for the current fiscal year.
Several equities analysts have weighed in on CERN shares. Piper Jaffray Companies lifted their target price on Cerner from $74.00 to $80.00 and gave the company an “overweight” rating in a research report on Thursday, July 25th. Canaccord Genuity boosted their price objective on Cerner from $77.00 to $80.00 and gave the stock a “buy” rating in a research report on Thursday, July 25th. ValuEngine downgraded Cerner from a “buy” rating to a “hold” rating in a research report on Wednesday, September 4th. KeyCorp reissued an “overweight” rating and set a $82.00 price objective (up from $76.00) on shares of Cerner in a research report on Friday, August 16th. Finally, Zacks Investment Research cut Cerner from a “buy” rating to a “hold” rating and set a $77.00 target price for the company. in a research note on Monday, July 29th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the company. Cerner currently has a consensus rating of “Buy” and an average price target of $74.73.
Large investors have recently added to or reduced their stakes in the company. Parametric Portfolio Associates LLC increased its holdings in shares of Cerner by 6.0% in the first quarter. Parametric Portfolio Associates LLC now owns 732,099 shares of the company’s stock valued at $41,883,000 after purchasing an additional 41,265 shares during the period. Janus Henderson Group PLC increased its holdings in shares of Cerner by 0.8% in the second quarter. Janus Henderson Group PLC now owns 367,043 shares of the company’s stock valued at $26,900,000 after purchasing an additional 2,859 shares during the period. Hartford Investment Management Co. increased its holdings in shares of Cerner by 0.3% in the second quarter. Hartford Investment Management Co. now owns 104,219 shares of the company’s stock valued at $7,639,000 after purchasing an additional 313 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its holdings in shares of Cerner by 54.0% in the first quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 501,092 shares of the company’s stock valued at $28,667,000 after purchasing an additional 175,676 shares during the period. Finally, FinTrust Capital Advisors LLC increased its holdings in shares of Cerner by 6,480.6% in the second quarter. FinTrust Capital Advisors LLC now owns 8,160 shares of the company’s stock valued at $598,000 after purchasing an additional 8,036 shares during the period. 82.66% of the stock is currently owned by institutional investors and hedge funds.
Cerner Company Profile
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Further Reading: What is Liquidity?
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.